Application 201635
- Type
- NDA
- Sponsor
- SUPERNUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TROKENDI XR | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 25MG | Yes | No |
| 002 | TROKENDI XR | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 50MG | Yes | No |
| 003 | TROKENDI XR | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 100MG | Yes | No |
| 004 | TROKENDI XR | TOPIRAMATE | CAPSULE, EXTENDED RELEASE;ORAL | 200MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N201635-001 | TROKENDI XR | TOPIRAMATE | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 |
| N201635-002 | TROKENDI XR | TOPIRAMATE | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 |
| N201635-003 | TROKENDI XR | TOPIRAMATE | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 |
| N201635-004 | TROKENDI XR | TOPIRAMATE | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N201635-001 | AB1 |
| N201635-002 | AB1 |
| N201635-003 | AB1 |
| N201635-004 | AB1 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N201635-001 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 |
| N201635-001 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 |
| N201635-001 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 |
| N201635-001 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 |
| N201635-001 | 8663683 | 2027-11-16 | U-106 | Drug product | |
| N201635-001 | 8663683 | 2027-11-16 | U-1992 | Drug product | |
| N201635-001 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 |
| N201635-001 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 |
| N201635-001 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | |
| N201635-001 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | |
| N201635-001 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 |
| N201635-001 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 |
| N201635-001 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 |
| N201635-001 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 |
| N201635-001 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 |
| N201635-001 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 |
| N201635-001 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 |
| N201635-001 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 |
| N201635-001 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 |
| N201635-001 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 |
| N201635-002 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 |
| N201635-002 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 |
| N201635-002 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 |
| N201635-002 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 |
| N201635-002 | 8663683 | 2027-11-16 | U-106 | Drug product | |
| N201635-002 | 8663683 | 2027-11-16 | U-1992 | Drug product | |
| N201635-002 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 |
| N201635-002 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 |
| N201635-002 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | |
| N201635-002 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | |
| N201635-002 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 |
| N201635-002 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 |
| N201635-002 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 |
| N201635-002 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 |
| N201635-002 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 |
| N201635-002 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 |
| N201635-002 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 |
| N201635-002 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 |
| N201635-002 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 |
| N201635-002 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 |
| N201635-003 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 |
| N201635-003 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 |
| N201635-003 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 |
| N201635-003 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 |
| N201635-003 | 8663683 | 2027-11-16 | U-106 | Drug product | |
| N201635-003 | 8663683 | 2027-11-16 | U-1992 | Drug product | |
| N201635-003 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 |
| N201635-003 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 |
| N201635-003 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | |
| N201635-003 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | |
| N201635-003 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 |
| N201635-003 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 |
| N201635-003 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 |
| N201635-003 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 |
| N201635-003 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 |
| N201635-003 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 |
| N201635-003 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 |
| N201635-003 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 |
| N201635-003 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 |
| N201635-003 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 |
| N201635-004 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 |
| N201635-004 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 |
| N201635-004 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 |
| N201635-004 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 |
| N201635-004 | 8663683 | 2027-11-16 | U-106 | Drug product | |
| N201635-004 | 8663683 | 2027-11-16 | U-1992 | Drug product | |
| N201635-004 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 |
| N201635-004 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 |
| N201635-004 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | |
| N201635-004 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | |
| N201635-004 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 |
| N201635-004 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 |
| N201635-004 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 |
| N201635-004 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 |
| N201635-004 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 |
| N201635-004 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 |
| N201635-004 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 |
| N201635-004 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 |
| N201635-004 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 |
| N201635-004 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-001 | TROKENDI XR | 25MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-002 | TROKENDI XR | 50MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-003 | TROKENDI XR | 100MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD | 2013-08-16 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-004 | TROKENDI XR | 200MG | CAPSULE, EXTENDED RELEASE / ORAL | AB1 | RLD, RS | 2013-08-16 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N201635-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-003 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N201635-004 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N201635-004 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-003 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N201635-004 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-002 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-003 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N201635-004 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-003 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N201635-004 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-002 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-003 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N201635-004 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-003 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N201635-004 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-003 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N201635-004 | AB1 | 1 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8663683 | 2027-11-16 | U-1992 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8663683 | 2027-11-16 | U-106 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-001 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 10314790 | 2027-11-16 | U-1992 | Drug product | 2019-07-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 10314790 | 2027-11-16 | U-1675 | Drug product | 2019-07-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8298580 | 2027-11-16 | U-106 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8298580 | 2027-11-16 | U-1992 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8663683 | 2027-11-16 | U-106 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8663683 | 2027-11-16 | U-1992 | Drug product | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8877248 | 2027-11-16 | U-1992 | Drug product | 2014-11-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8877248 | 2027-11-16 | U-106 | Drug product | 2014-11-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8889191 | 2027-11-16 | U-106 | 2014-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8889191 | 2027-11-16 | U-1992 | 2014-12-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8992989 | 2027-11-16 | U-1675 | Drug product | 2015-04-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8992989 | 2027-11-16 | U-1992 | Drug product | 2015-04-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9549940 | 2027-11-16 | U-1992 | Drug product | 2017-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9549940 | 2027-11-16 | U-1675 | Drug product | 2017-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9555004 | 2027-11-16 | U-1992 | Drug product | 2017-02-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9555004 | 2027-11-16 | U-1675 | Drug product | 2017-02-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9622983 | 2027-11-16 | U-1992 | Drug product | 2017-04-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 9622983 | 2027-11-16 | U-1675 | Drug product | 2017-04-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8298576 | 2028-04-04 | U-1992 | Drug product | 2013-08-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N201635-002 | 8298576 | 2028-04-04 | U-106 | Drug product | 2013-08-22 | 84e616aacf4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 2f5b1b0b-fd8a-4c4e-a85a-519ca841a0db | 2026-05-19 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Upsher-Smith Laboratories, LLC | 691d276c-9cc1-4d39-828f-0f44d7ef6328 | 2026-05-15 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Vitruvias Therapeutics, Inc. | a9d7c5ef-daf9-4f97-8673-7f4a2007f408 | 2026-05-07 | Warnings, Adverse reactions | TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 54bfabce-1f8a-40ee-8b55-efce8fe6fbf1 | 2026-04-30 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 149d20de-f262-4567-aa97-d4d28a1653cb | 2026-04-30 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | Coupler LLC | 50b10a3d-883c-8891-e063-6394a90a86a1 | 2026-04-30 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 872927eb-0b61-44bb-9892-3c700b6f2181 | 2026-04-29 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | Quallent Pharmaceuticals Health LLC | 9dae6824-6913-42de-b98a-cdcb0d3b4a46 | 2026-04-25 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | e4886adf-199d-4b19-a4ef-75f8f94cb54e | 2026-04-22 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Ajanta Pharma USA Inc. | b94629e3-ae2e-473e-b2f5-06e32ee19aa9 | 2026-04-20 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | a5ca2fce-bd2d-40db-b963-e3ec27c8bf23 | 2026-04-16 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | 67dcdd6e-48bc-418e-a887-805929d83ce0 | 2026-04-15 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 35312f49-decf-428d-bf5f-4215b762ed3c | 2026-04-10 | Warnings, Adverse reactions | TOPIRAMATE |
| topiramate | TOPIRAMATE | Unichem Pharmaceuticals (USA), Inc. | 6ee00e82-799d-445e-b658-a9712c49a28e | 2026-04-06 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Advagen Pharma Ltd | 48169bbc-4fb2-4bc4-9bdd-de71bf7722df | 2026-04-03 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Teva Pharmaceuticals, Inc. | 4f20155f-05b9-40ec-af34-3b58aa8d60d4 | 2026-04-01 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | f72774dd-c7eb-41f9-9837-02baf77cc523 | 2026-03-30 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Lupin Pharmaceuticals, Inc. | e310afcd-1260-434e-a994-34549c789d99 | 2026-03-30 | Warnings, Adverse reactions | TOPIRAMATE |
| Topiramate | TOPIRAMATE | Aurobindo Pharma Limited | 32b48ea0-a215-43b8-83b4-a5435a686d68 | 2026-03-24 | Warnings, Adverse reactions | TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Aurobindo Pharma Limited | d1588c37-9da9-4ccb-b78a-64234938a115 | 2026-03-24 | Warnings, Adverse reactions | TOPIRAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-101 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-102 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-103 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
| 17772-104 | Trokendi XR | topiramate | Supernus Pharmaceuticals | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85337 | SUPPL | 2026-03-12 |
| 85300 | SUPPL | 2026-03-09 |
| 85353 | SUPPL | 2026-03-06 |
| 82130 | SUPPL | 2025-05-01 |
| 82129 | SUPPL | 2025-05-01 |
| 81538 | SUPPL | 2025-03-12 |
| 81534 | SUPPL | 2025-03-11 |
| 77201 | SUPPL | 2024-01-10 |
| 77190 | SUPPL | 2024-01-05 |
| 72307 | SUPPL | 2022-10-11 |
| 72306 | SUPPL | 2022-10-11 |
| 72284 | SUPPL | 2022-10-11 |
| 70100 | SUPPL | 2022-02-07 |
| 70099 | SUPPL | 2022-02-07 |
| 70073 | SUPPL | 2022-02-04 |
| 65294 | SUPPL | 2020-11-19 |
| 65279 | SUPPL | 2020-11-19 |
| 65278 | SUPPL | 2020-11-19 |
| 57792 | SUPPL | 2019-02-22 |
| 57774 | SUPPL | 2019-02-22 |
| 50973 | SUPPL | 2018-01-09 |
| 50972 | SUPPL | 2018-01-04 |
| 47955 | SUPPL | 2017-04-12 |
| 47903 | SUPPL | 2017-04-07 |
| 47902 | SUPPL | 2017-04-07 |
| 47901 | SUPPL | 2017-04-07 |
| 45099 | SUPPL | 2016-08-22 |
| 45227 | SUPPL | 2016-08-18 |
| 45141 | SUPPL | 2016-08-18 |
| 40076 | SUPPL | 2015-06-05 |
| 32125 | SUPPL | 2015-05-13 |
| 43369 | ORIG | 2014-06-24 |
| 24397 | ORIG | 2014-06-24 |
| 19027 | ORIG | 2013-08-21 |
| 9914 | ORIG | 2013-08-20 |
| 32124 | ORIG | 2013-06-11 |
| 32123 | ORIG | 2012-06-26 |